0116 289 7162
Long lasting, stable Haemostasis, without compression
Effective control of all types of surgical bleeds, including moderate and severe
Fully implantable and completely Bioabsorbed within 7 days
Unlike Oxidised Regenerated Cellulose haemostats, that weaken and break the cellulose structure via the oxidation process Woundclot strengthens it through the insertion of functional molecular groups across the structural backbone. Woundclot is the first non-oxidised cellulose based haemostat; science to improve surgical outcomes.
- Increased absorption capability: >2500%
- Increased structural strength: can be used for severe bleeds
- Promotes the activation of Factor XII
- Utilises hydration forces to achieve non compression haemostasis
- Creates a haemodynamic environment
- Facilitates the fast formation of a biological clot
Simulated Liver biopsy – Porcine model, Non-compression haemostasis
Injury to Spleen, Porcine model, Non-compression haemostasis
Femoral artery laceration, Non-compression haemostasis
Absorption profile ofthe first 24 hours of Woundclot and ORC Hemostat in water.
The functional molecular groups that are inserted into the cellulose structure during the manufacturing process, have been designed to confer unique physical and performance characteristics to the product.
By increasing the blood affinity into the product and providing a stable gel membrane even in the face of severe bleeding, Woundclot facilitates faster, and more stable, biological clot formation.
The 3D matrix membrane formed in the presence of blood, creates a haemodynamic environment which entraps platelets and coagulants; serving to slow the blood flow and allow for a rapid increase in their activity, speeding up both platelet plug formation and promotion of the clotting process. The functional molecular group interacts with activated platelet derived polyphosphates, significantly increasing the promotion of activated Hageman Factor, when compared to other dissolvable haemostats. (fig.1).
The truly unique function of the molecular groups however, is the ability of the product to both utilise and maximise the principle of hydration forces, allowing for haemostasis to be achieved, without the need for compression. The principle of hydration forces enable Woundclot to adhere to the site of surgical bleeding and facilitate the formation of a biological clot, even in the face of severe arterial and venous bleeds.
The principle ensures that the stronger the pressure of the bleed, the greater the attraction force subjected to the product. It is this unique property that enables the product to achieve haemostasis in situations not previously associated with Cellulose based haemostats.
Hageman Factor promotion profile of dissolvable Hemostats (fig.1).
Product application
Woundclot is applied to a bleeding site via the Soak Soak Place method of application
• Unfold into a single layer and gently place the product over the wound or site of bleeding
• Ensuring that the fingers do not touch the actual wound, make sure the gauze is soaked with blood
• Gently place the product flat onto the wound, ensuring that the edges extend over the wound margins. These shoulders are important to observe, for as the product becomes a gel membrane, it will begin to shrink
• The gel membrane that is formed will adhere to the wound, stem the blood flow and and stop the bleeding as it breaks down
• Once haemostasis is achieved, the product can easily be removed leaving the functional clot undisturbed
• Non-compression haemostasis
• Fully bioabsorbed within 7 days
• Creates a haemodynamic environment
• Effective bleeding control in all types of surgical scenarios
• Modified cellulose structure, not oxidised
• Fast and stable biological clot formation
• Can be left in situ, or removed once haemostasis is achieved
• Natural product with no added human protein
Find Us